Farukh A. Durrani

Selective Modulation of the Therapeutic Efficacy of Anticancer Drugs by Selenium Containing Compounds against Human Tumor Xenografts

Shousong Cao, Farukh A. Durrani, Youcef M. Rustum · Clinical Cancer Research · 2004 · 225 citations

Medicine, Oncology, Pharmacology +12

Therapeutic Synergy Between Irinotecan and 5-Fluorouracil against Human Tumor Xenografts

Rami G. Azrak, Shousong Cao, Harry K. Slocum et al. · Clinical Cancer Research · 2004 · 100 citations

Medicine, Oncology, Pharmacology +17

Highly Effective Dual-Function Near-Infrared (NIR) Photosensitizer for Fluorescence Imaging and Photodynamic Therapy (PDT) of Cancer

Nayan J. Patel, Paula Pera, Penny Joshi et al. · Journal of Medicinal Chemistry · 2016 · 95 citations

Medicine, Oncology, Pharmacology +17

Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition

Sreenivasulu Chintala, Tanbir Najrana, Károly Tóth et al. · BMC Cancer · 2012 · 78 citations · Full text

Medicine, Oncology, Pharmacology +17

Se-methylselenocysteine offers selective protection against toxicity and potentiates the antitumour activity of anticancer drugs in preclinical animal models

Shousong Cao, Farukh A. Durrani, Károly Tóth et al. · British Journal of Cancer · 2014 · 74 citations · Full text

Medicine, Oncology, Pharmacology +17